?:authorAffiliation
|
-
[\'Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX, USA.\', \'Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.\', \'Center for Outcomes Research, Houston Methodist Research Institute, Houston, TX, USA.\', \'Houston Methodist Neurological Institute, Houston Methodist, Houston, TX, USA.\', \'Department of Pharmaceutics, University of Washington, Seattle, WA, USA.\', \'Dompé X-Therapeutics, San Mateo, CA, USA.\', \'Rutgers Cancer Institute of New Jersey, Newark, NJ, USA.\', \'Department of Radiation Oncology, Division of Cancer Biology, Rutgers New Jersey Medical School, Newark, NJ, USA.\', \'Department of Medicine, Division of Hematology/Oncology, Rutgers New Jersey Medical School, Newark, NJ, USA.\', \'Department of Medicine, Houston Methodist, Houston, TX, USA.\', \'Weill Cornell Medicine, New York, NY, USA.\', \'Houston Methodist Research Institute, Houston, TX, USA.\', \'Houston Methodist Academic Institute, Houston, TX, USA.\', \'Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX, USA. vcristini@houstonmethodist.org.\']
|